πŸ‡ΊπŸ‡Έ FDA
Patent

US 11696893

Preparation comprising vonoprazan

granted A61KA61K31/4439A61K47/12

Quick answer

US patent 11696893 (Preparation comprising vonoprazan) held by Takeda Pharmaceutical Company Limited expires Mon Jul 06 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Jul 11 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 06 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K31/4439, A61K47/12, A61K9/0056, A61K9/14